Multiple juvenile idiopathic arthritis subtypes demonstrate proinflammatory IgG glycosylation

Arthritis and Rheumatism

Volumn 64, Issue 9, 2012, Pages 3025-3033

  Ercan, Altan ^a   Barnes, Michael G ^b   Hazen, Melissa ^c   Tory, Heather ^c   Henderson, Lauren ^c   Dedeoglu, Fatma ^c   Fuhlbrigge, Robert C ^c   Grom, Alexei ^b   Holm, Ingrid A ^c   Kellogg, Mark ^c   Kim, Susan ^c   Adamczyk, Barbara ^d   Rudd, Pauline M ^d   Son, Mary Beth ^c   Sundel, Robert P ^c   Foell, Dirk ^e   Glass, David N ^b   Thompson, Susan D ^b   Nigrovic, Peter A ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d UNIVERSITY COLLEGE DUBLIN   (Ireland)

^e UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; DISEASE MODIFYING ANTIRHEUMATIC DRUG; GLYCAN; IMMUNOGLOBULIN G;

ADOLESCENT; ARTICLE; CHILD; CHILDHOOD; CONTROLLED STUDY; ENTHESITIS; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INFANT; JUVENILE RHEUMATOID ARTHRITIS; MALE; ONSET AGE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; SCHOOL CHILD;

ADOLESCENT; ARTHRITIS, JUVENILE RHEUMATOID; CHILD; CHILD, PRESCHOOL; FEMALE; GLYCOSYLATION; HUMANS; IMMUNOGLOBULIN G; INFANT; INFLAMMATION; MALE;

EID: 84865637801     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.34507     Document Type: Article

References (47)

1. Murray KJ, Moroldo MB, Donnelly P, Prahalad S, Passo MH, Giannini EH, et al. Age-specific effects of juvenile rheumatoid arthritis-associated HLA alleles. Arthritis Rheum 1999; 42: 1843-53.
2. Hollenbach JA, Thompson SD, Bugawan TL, Ryan M, Sudman M, Marion M, et al. Juvenile idiopathic arthritis and HLA class I and class II interactions and age-at-onset effects. Arthritis Rheum 2010; 62: 1781-91.
3. Rynes RI, Ruddy S, Spragg J, Stillman JS, Austen KF,. Intraarticular activation of the complement system in patients with juvenile rheumatoid arthritis. Arthritis Rheum 1976; 19: 161-8.
4. Moore TL, Sheridan PW, Traycoff RB, Zuckner J, Dorner RW,. Immune complexes in juvenile rheumatoid arthritis: a comparison of four methods. J Rheumatol 1982; 9: 395-401.
5. Jarvis JN, Taylor H, Iobidze M, Krenz M,. Complement activation and immune complexes in children with polyarticular juvenile rheumatoid arthritis: a longitudinal study. J Rheumatol 1994; 21: 1124-7.
6. Mor-Vaknin N, Kappes F, Dick AE, Legendre M, Damoc C, Teitz-Tennenbaum S, et al. DEK in the synovium of patients with juvenile idiopathic arthritis: characterization of DEK antibodies and posttranslational modification of the DEK autoantigen. Arthritis Rheum 2011; 63: 556-67.
7. Sullivan DB, Cassidy JT, Petty RE,. Pathogenic implications of age of onset in juvenile rheumatoid arthritis. Arthritis Rheum 1975; 18: 251-5.
8. Saurenmann RK, Levin AV, Feldman BM, Laxer RM, Schneider R, Silverman ED,. Risk factors for development of uveitis differ between girls and boys with juvenile idiopathic arthritis. Arthritis Rheum 2010; 62: 1824-8.
9. Stoll ML, Zurakowski D, Nigrovic LE, Nichols DP, Sundel RP, Nigrovic PA,. Patients with juvenile psoriatic arthritis comprise two distinct populations. Arthritis Rheum 2006; 54: 3564-72.
10. Stoll ML, Lio P, Sundel RP, Nigrovic PA,. Comparison of Vancouver and International League of Associations for rheumatology classification criteria for juvenile psoriatic arthritis. Arthritis Rheum 2008; 59: 51-8.
11. Ogilvie EM, Fife MS, Thompson SD, Twine N, Tsoras M, Moroldo M, et al. The -174G allele of the interleukin-6 gene confers susceptibility to systemic arthritis in children: a multicenter study using simplex and multiplex juvenile idiopathic arthritis families. Arthritis Rheum 2003; 48: 3202-6.
12. Lewis DB, Tu W,. The physiologic immunodeficiency of immaturity. In:, Stiehm ER, Ochs HD, Winkelstein JA, editors. Immunologic disorders in infants and children. 5th ed. Philadelphia: Elsevier Saunders; 2004. p. 687-760.
13. Stiehm ER, Fudenberg HH,. Serum levels of immune globulins in health and disease: a survey. Pediatrics 1966; 37: 715-27.
14. Smith DH, Peter G, Ingram DL, Harding AL, Anderson P,. Responses of children immunized with the capsular polysaccharide of Hemophilus influenzae, type b. Pediatrics 1973; 52: 637-44.
15. Raju TS,. Terminal sugars of Fc glycans influence antibody effector functions of IgGs. Curr Opin Immunol 2008; 20: 471-8.
16. Sondermann P, Huber R, Oosthuizen V, Jacob U,. The 3.2-A crystal structure of the human IgG1 Fc fragment-Fc γRIII complex. Nature 2000; 406: 267-73.
17. Anthony RM, Ravetch JV,. A novel role for the IgG Fc glycan: the anti-inflammatory activity of sialylated IgG Fcs. J Clin Immunol 2010; 30 Suppl 1: S9-14.
18. Malhotra R, Wormald MR, Rudd PM, Fischer PB, Dwek RA, Sim RB,. Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein. Nat Med 1995; 1: 237-43.
19. Arnold JN, Dwek RA, Rudd PM, Sim RB,. Mannan binding lectin and its interaction with immunoglobulins in health and in disease. Immunol Lett 2006; 106: 103-10.
20. Banda NK, Wood AK, Takahashi K, Levitt B, Rudd PM, Royle L, et al. Initiation of the alternative pathway of murine complement by immune complexes is dependent on N-glycans in IgG antibodies. Arthritis Rheum 2008; 58: 3081-9.
21. Parekh R, Roitt I, Isenberg D, Dwek R, Rademacher T,. Age-related galactosylation of the N-linked oligosaccharides of human serum IgG. J Exp Med 1988; 167: 1731-6.
22. Yamada E, Tsukamoto Y, Sasaki R, Yagyu K, Takahashi N,. Structural changes of immunoglobulin G oligosaccharides with age in healthy human serum. Glycoconj J 1997; 14: 401-5.
23. Parekh RB, Dwek RA, Sutton BJ, Fernandes DL, Leung A, Stanworth D, et al. Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG. Nature 1985; 316: 452-7.
24. Parekh RB, Roitt IM, Isenberg DA, Dwek RA, Ansell BM, Rademacher TW,. Galactosylation of IgG associated oligosaccharides: reduction in patients with adult and juvenile onset rheumatoid arthritis and relation to disease activity. Lancet 1988; 1: 966-9.
25. Sumar N, Isenberg DA, Bodman KB, Soltys A, Young A, Leak AM, et al. Reduction in IgG galactose in juvenile and adult onset rheumatoid arthritis measured by a lectin binding method and its relation to rheumatoid factor. Ann Rheum Dis 1991; 50: 607-10.
26. Watson M, Rudd PM, Bland M, Dwek RA, Axford JS,. Sugar printing rheumatic diseases: a potential method for disease differentiation using immunoglobulin G oligosaccharides. Arthritis Rheum 1999; 42: 1682-90.
27. Van Beneden K, Coppieters K, Laroy W, De Keyser F, Hoffman IE, Van den Bosch F, et al. Reversible changes in serum immunoglobulin galactosylation during the immune response and treatment of inflammatory autoimmune arthritis. Ann Rheum Dis 2009; 68: 1360-5.
28. Ercan A, Cui J, Chatterton DE, Deane KD, Hazen MM, Brintnell W, et al. Aberrant IgG galactosylation precedes disease onset, correlates with disease activity, and is prevalent in autoantibodies in rheumatoid arthritis. Arthritis Rheum 2010; 62: 2239-48.
29. Ercan A, Cui J, Hazen MM, Batliwalla F, Royle L, Rudd PM, et al. Hypogalactosylation of IgG fails to predict clinical response to methotrexate and TNF inhibition in rheumatoid arthritis. Arthritis Res Ther 2012; 14: R43.
30. Scherer HU, van der Woude D, Ioan-Facsinay A, el Bannoudi H, Trouw LA, Wang J, et al. Glycan profiling of anti-citrullinated protein antibodies isolated from human serum and synovial fluid. Arthritis Rheum 2010; 62: 1620-9.
31. Rademacher TW, Williams P, Dwek RA,. Agalactosyl glycoforms of IgG autoantibodies are pathogenic. Proc Natl Acad Sci U S A 1994; 91: 6123-7.
32. Flogel M, Lauc G, Gornik I, Macek B,. Fucosylation and galactosylation of IgG heavy chains differ between acute and remission phases of juvenile chronic arthritis. Clin Chem Lab Med 1998; 36: 99-102.
33. Bond A, Alavi A, Axford JS, Youinou P, Hay FC,. The relationship between exposed galactose and N-acetylglucosamine residues on IgG in rheumatoid arthritis (RA), juvenile chronic arthritis (JCA) and Sjogren's syndrome (SS). Clin Exp Immunol 1996; 105: 99-103.
34. Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 2004; 31: 390-2.
35. Royle L, Campbell MP, Radcliffe CM, White DM, Harvey DJ, Abrahams JL, et al. HPLC-based analysis of serum N-glycans on a 96-well plate platform with dedicated database software. Anal Biochem 2008; 376: 1-12.
36. Roth J, Burwinkel F, van den Bos C, Goebeler M, Vollmer E, Sorg C,. MRP8 and MRP14, S-100-like proteins associated with myeloid differentiation, are translocated to plasma membrane and intermediate filaments in a calcium-dependent manner. Blood 1993; 82: 1875-83.
37. Martini A,. Are the number of joints involved or the presence of psoriasis still useful tools to identify homogeneous disease entities in juvenile idiopathic arthritis? J Rheumatol 2003; 30: 1900-3.
38. Omtvedt LA, Royle L, Husby G, Sletten K, Radcliffe CM, Harvey DJ, et al. Glycan analysis of monoclonal antibodies secreted in deposition disorders indicates that subsets of plasma cells differentially process IgG glycans. Arthritis Rheum 2006; 54: 3433-40.
39. Wang J, Balog CI, Stavenhagen K, Koeleman CA, Scherer HU, Selman MH, et al. Fc-glycosylation of IgG1 is modulated by B-cell stimuli. Mol Cell Proteomics 2011; 10: M110 004655.
40. Banda NK, Thurman JM, Kraus D, Wood A, Carroll MC, Arend WP, et al. Alternative complement pathway activation is essential for inflammation and joint destruction in the passive transfer model of collagen-induced arthritis. J Immunol 2006; 177: 1904-12.
41. Banda NK, Takahashi K, Wood AK, Holers VM, Arend WP,. Pathogenic complement activation in collagen antibody-induced arthritis in mice requires amplification by the alternative pathway. J Immunol 2007; 179: 4101-9.
42. Barnes MG, Grom AA, Thompson SD, Griffin TA, Pavlidis P, Itert L, et al. Subtype-specific peripheral blood gene expression profiles in recent-onset juvenile idiopathic arthritis. Arthritis Rheum 2009; 60: 2102-12.
43. Barnes MG, Grom AA, Thompson SD, Griffin TA, Luyrink LK, Colbert RA, et al. Biologic similarities based on age at onset in oligoarticular and polyarticular subtypes of juvenile idiopathic arthritis. Arthritis Rheum 2010; 62: 3249-58.
44. Ravelli A, Varnier GC, Oliveira S, Castell E, Arguedas O, Magnani A, et al. Antinuclear antibody-positive patients should be grouped as a separate category in the classification of juvenile idiopathic arthritis. Arthritis Rheum 2011; 63: 267-75.
45. Myasoedova E, Crowson CS, Kremers HM, Therneau TM, Gabriel SE,. Is the incidence of rheumatoid arthritis rising? Results from Olmsted County, Minnesota, 1955-2007. Arthritis Rheum 2010; 62: 1576-82.
46. Nigrovic PA, White PH,. Care of the adult with juvenile rheumatoid arthritis. Arthritis Rheum 2006; 55: 208-16.
47. Harvey DJ, Merry AH, Royle L, Campbell MP, Dwek RA, Rudd PM,. Proposal for a standard system for drawing structural diagrams of N- and O-linked carbohydrates and related compounds. Proteomics 2009; 9: 3796-801.